Log in
Enquire now
‌

US Patent 10329314 Soluble C5aR antagonists

Patent 10329314 was granted and assigned to ChemoCentryx on June, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
ChemoCentryx
ChemoCentryx
Current Assignee
ChemoCentryx
ChemoCentryx
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10329314
Patent Inventor Names
Penglie Zhang0
Pingchen Fan0
Shichang Miao0
Sreenivas Punna0
Valentino J. Stella0
Venkat Reddy Mali0
Yang Song0
Yibin Zeng0
...
Date of Patent
June 25, 2019
Patent Application Number
15908508
Date Filed
February 28, 2018
Patent Citations Received
‌
US Patent 12006366 Methods and compositions for preventing type 1 diabetes
0
‌
US Patent 11479553 5-5 fused rings as C5a inhibitors
‌
US Patent 11485737 Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
0
‌
US Patent 11254695 Soluble C5aR antagonists
0
‌
US Patent 11608336 Prodrugs of fused-bicyclic C5aR antagonists
0
‌
US Patent 11773091 6-5 fused rings as C5a inhibitors
‌
US Patent 11434291 Methods and compositions for preventing type 1 diabetes
‌
US Patent 11951214 Capsule formulations
0
...
Patent Primary Examiner
‌
Sahar Javanmard
Patent abstract

Compounds are provided to modulate the C5a receptor. The compounds have the following Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10329314 Soluble C5aR antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.